To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 13, 2020)
This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD.
The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.
What just happenedJan 23, 2020
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Who’s behind it
- Introduced in HouseJan 13, 2020
- Jan 23, 2020Committee
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Conservation, Research, and Biotechnology Subcommittee - Jan 13, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Agriculture Committee - Jan 13, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 13, 2020IntroReferralIntro-H
Introduced in House
- Jan 13, 2020IntroReferral1000
Introduced in House